LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)
Azienda Sanitaria Ospedaliera
50 participants
Jan 15, 2024
INTERVENTIONAL
Conditions
Summary
LITALHICA is a prospective non-randomized study aimed at exploring the outcome of liver transplantation in selected patients with unresectable perihilar cholangiocarcinoma (pCCA) after treatment with standard of care chemotherapy, in terms of overall survival and quality of life. Additionally, the study aims to identify pre-transplant biological markers and clinical factors that can stratify patients with the best post-transplant prognosis. Finally, the study aims to investigate the role of preoperative PET-MRI, especially in relation to lymph node locations, by correlating the results with histological examination after hilar lymphadenectomy.
Eligibility
Inclusion Criteria7
- Diagnosis of pCCA (transcatheter biopsy or brush cytology, CA 19-9 \> 100 mg/mL and/or a mass on cross-sectional imaging with a malignant appearing stricture on cholangiography, or biliary ploidy with a malignant appearing stricture on cholangiography)
- Unresectable tumor above cystic duct (pancreatoduodenectomy for microscopic involvement of CBD) or resectable pCCA arising in PSC
- Absence of major vascular invasion, extrahepatic disease, or involvement of regional lymph nodes
- No extrahepatic metastatic disease
- Radial tumor diameter \<3 cm
- At least six months between first diagnosis of pCCA and date of inclusion
- At least six months of SOC chemotherapy, achieving disease stability or partial response
Exclusion Criteria11
- Uncontrollable infection
- Prior radiotherapy or chemotherapy
- Prior biliary surgical resection or attempted surgical resection
- Diameter of tumor \>3cm
- Presence of intra-hepatic metastases or iCCA
- Present or past evidence of extrahepatic metastatic disease
- Transperitoneal biopsy (including percutaneous ecography-guided FNA)
- Prior neoplasms, except those treated curatively for more than 5 years without recurrence
- Substance abuse and medical, psychological, or social conditions that may interfere with the patient's participation in the study
- Pregnant or breastfeeding women
- Medical-surgical contraindications for liver transplantation
Interventions
Patients will undergo liver transplantation according to the standard procedures of the institutional Center's protocol (cadaveric or living donor transplantation, whole or partial liver). Liver transplantation is preceded by an exploratory laparotomy with clinical evaluation and frozen section examination of lymph nodes in the hepatoduodenal ligament and along the common hepatic artery/celiac axis.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06125769